AVR 3.10% $17.20 anteris technologies ltd

Admedus dominating in Europe., page-53

  1. 17,506 Posts.
    lightbulb Created with Sketch. 416
    "TAVR is only an option for patients who are at intermediate or greater risk for open heart surgery. "

    This is a comment from a linked site when one goggles TAVR

    To my mind this means it is only suitable for a limited proportion of patients ie those who could not potentially survive open heart surgery.

    Ie : risky
    Ie : before it gets into use must be tried and tested
    If any one thinks that's gunna happen overnight then perhaps think again

    I wonder sometimes if folk think I am anti AHZ
    - I am not but what really irks me is some posters unrealistic ideas .
    AHZ has gone from that exciting story , the hype about its potential to now a real business that has to battle in a the real market
    ( liken it to a mining company that had the hype of drilling holes and the speculation of what it would find but when it comes to a mine that's much harde )
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.20
Change
-0.550(3.10%)
Mkt cap ! $330.6M
Open High Low Value Volume
$17.75 $17.75 $16.88 $199.1K 11.56K

Buyers (Bids)

No. Vol. Price($)
1 500 $17.00
 

Sellers (Offers)

Price($) Vol. No.
$17.24 1000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.